AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

TRANDOLAPRIL

32 registrations across 4 African markets— 17 active

Markets with TRANDOLAPRIL

🇿🇦South Africa
24 registrations
12 active
🇲🇦Morocco
3 registrations
3 active
🇹🇳Tunisia
3 registrations
0 active
🇿🇼Zimbabwe
2 registrations
2 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
MAVIK
CAPSULE; ORAL
🇿🇼ZimbabweABBOTT LABORATORIES SA (PTY) LTDactiveDec 2027
MAVIK
CAPSULE; ORAL
🇿🇼ZimbabweABBOTT LABORATORIES SA (PTY) LTDactiveDec 2027
TANLIM 1 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedJun 2023
TANLIM 4 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedJun 2023
TANLIM 0,5 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedJun 2023
TANLIM 2 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedJun 2023
KIVAM 4 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedSept 2022
TENZIK 2 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedSept 2022
TENZIK 4 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedSept 2022
KIVAM 1 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedSept 2022
KIVAM 2 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedSept 2022
TENZIK 0,5 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedSept 2022
KIVAM 0,5 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedSept 2022
TENZIK 1 mg CAPSULES🇿🇦South AfricaAurogen South Africa (Pty) LtdsuspendedSept 2022
ODRIK
Gélule / 2 mg
🇹🇳TunisiaMYLAN MEDICAL SASexpiredJul 2017
ODRIK
Gélule / 0.5 mg
🇹🇳TunisiaMYLAN MEDICAL SASexpiredJul 2017
ODRIK
Gélule / 4 mg
🇹🇳TunisiaMYLAN MEDICAL SASexpiredJul 2017
TARKA 180/2🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
MAVIK 4 mg🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
TARKA🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
MAVIK 0,5 mg🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
TRANDOPRESS 2 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
TRANDOPRESS 0,5 mg🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
ACTI-TRAN 4 MG🇿🇦South AfricaActivo Health (Pty) LtdactiveJan 1900
ACTI-TRAN 2 MG🇿🇦South AfricaActivo Health (Pty) LtdactiveJan 1900
ACTI-TRAN 0,5 MG🇿🇦South AfricaActivo Health (Pty) LtdactiveJan 1900
MAVIK 1 mg🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
MAVIK 2 mg🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
TARKA 240/4🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
ODRIK
GELULE
🇲🇦Morocco—active—
ODRIK
GELULE
🇲🇦Morocco—active—
ODRIK 2 MG
GELULE
🇲🇦Morocco—active—

TRANDOLAPRIL in Africa — Regulatory Overview

TRANDOLAPRIL is registered across 4 African markets with 32 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Tunisia, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 32 registrations, 17 (53%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.